{
    "organizations": [],
    "uuid": "62778b6601e5496cef9bccf496ed07ee99f14bd2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-pixium-vision-fy-operating-loss-wi/brief-pixium-vision-fy-operating-loss-widens-to-12-7-million-euros-idUSFWN1PX1MB",
    "ord_in_thread": 0,
    "title": "BRIEF-Pixium Vision FY Operating Loss Widens to 12.7‍​ Million Euros",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 8 (Reuters) - PIXIUM VISION SA:\n* FY REVENUE EUR ‍​2.5 MILLION VERSUS EUR 2.5 MILLION YEAR AGO\n* FY OPERATING LOSS EUR 12.7‍​ MILLION VERSUS LOSS OF EUR 12.5 MILLION YEAR AGO\n* FY NET LOSS EUR 13.5‍​ MILLION VERSUS LOSS OF EUR 12.4 MILLION YEAR AGO\n* FEASIBILITY CLINICAL STUDY WITH PRIMA SHOULD START WITH FIRST IMPLANTATIONS IN THE FIRST HALF OF 2018‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-08T14:13:00.000+02:00",
    "crawled": "2018-02-09T17:11:00.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "pixium",
        "vision",
        "sa",
        "fy",
        "revenue",
        "eur",
        "million",
        "versus",
        "eur",
        "million",
        "year",
        "ago",
        "fy",
        "operating",
        "loss",
        "eur",
        "million",
        "versus",
        "loss",
        "eur",
        "million",
        "year",
        "ago",
        "fy",
        "net",
        "loss",
        "eur",
        "million",
        "versus",
        "loss",
        "eur",
        "million",
        "year",
        "ago",
        "feasibility",
        "clinical",
        "study",
        "prima",
        "start",
        "first",
        "implantation",
        "first",
        "half",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}